Print | Need Larger Text?

Incident Report

Subform I: General Information

1. Report Type.

New incident report

Incident Report Number: 2026-2037

2. Registrant Information.

Registrant Reference Number: CTVAS007-2024

Registrant Name (Full Legal Name no abbreviations): Corteva Agriscience Canada Company

Address: 240, 115 Quarry Park Road S.E.

City: Calgary

Prov / State: Alberta

Country: Canada

Postal Code: T2C 5G9

3. Select the appropriate subform(s) for the incident.

Scientific Study

4. Date registrant was first informed of the incident.

5. Location of incident.

6. Date incident was first observed.

Product Description

7. a) Provide the active ingredient and, if available, the registration number and product name (include all tank mixes). If the product is not registered provide a submission number.

PMRA Registration No.       PMRA Submission No.       EPA Registration No. Unknown

Product Name: GF-3565

• Active Ingredient(s)
  • FLORPYRAUXIFEN (PRESENT AS BENZYL ESTER)

7. b) Type of formulation.

Application Information

8. Product was applied?

Unknown

9. Application Rate.

10. Site pesticide was applied to (select all that apply).

11. Provide any additional information regarding application (how it was applied, amount applied, the size of the area treated etc).

To be determined by Registrant

12. In your opinion, was the product used according to the label instructions?

Unknown

Subform VII: Scientific Study

1. Study Reference

Title GF-3565: Toxicity to the Duckweed Lemna gibba under Laboratory Conditions (Acute Test - Semi-Static)

Date 15-MAR-19

2. a) Is an extension needed to translate the document?

No

3. Type of incident identified in the study

Increased health or environmental risk

4. Describe the incident identified in the study (e.g. study demonstrates an increased risk to non-Hodgkin's Lymphoma after exposure to pesticide X)

This study may fall under regulation related to "More than 50 percent of aquatic plants show adverse effects on plant life cycle functions and growth such as germination, emergence, plant vigour, reproduction and yields."

5. a) Was the study discontinued before completion?

No

5. b) Provide the reason for discontinuation

6. If the study is ongoing, what is the expected completion date?

For Registrant use only

7. Provide supplemental information here

The studies conducted on the coformulation GF-3565 (florpyrauxifen-benzyl plus penoxsulam) cannot be directly extrapolated to florpyrauxifen-benzyl (Rinskor) alone because the formulation contains an additional active that can influence toxicity and biological effects. Therefore, toxicity values derived from the mixture do not accurately represent the effects of florpyrauxifen-benzyl alone.